Clinical Trials Directory

Trials / Completed

CompletedNCT02811536

Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)

Status
Completed
Phase
Study type
Observational
Enrollment
440 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases

Detailed description

Optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that employs motion contrast imaging to high-resolution volumetric blood flow information. OCTA compares the decorrelation signal between sequential OCT b-scans taken at precisely the same cross-section in order to construct a map of blood flow. At present, level 1 evidence of the technology's clinical applications doesn't exist. The investigators plan to compare OCTA as an imaging modality to conventional imaging modalities used in clinical routine.

Conditions

Interventions

TypeNameDescription
DEVICEoptical coherence tomography angiographyImaging with optical coherence tomography angiography

Timeline

Start date
2017-02-13
Primary completion
2022-11-25
Completion
2022-11-25
First posted
2016-06-23
Last updated
2022-11-29

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02811536. Inclusion in this directory is not an endorsement.